US Patent Issued to Cerner Innovation on Oct. 14 for "Forecasting acute inflammatory condition and decision support tool" (Washington Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,170, issued on Oct. 14, was assigned to Cerner Innovation Inc. (Kansas City, Mo.).

"Forecasting acute inflammatory condition and decision support tool" was invented by Douglas S. McNair (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "A catastrophe-theoretic approach is provided for predicting an occurrence of an acute inflammatory condition or event (e.g., SIRS or sepsis) for a human patient based on a time series of monitored vital signs values measured from a patient, and in some instances, for providing advanced notice to clinicians or caregivers when such an acute inflammatory event is forecasted or modifying treatment for the patient, a...